Cargando…
The impact of MFG-E8 in chronic pancreatitis: potential for future immunotherapy?
BACKGROUND: The glycoprotein MFG-E8 mediates phagocytic clearance of apoptotic cells and influences the pathogenesis and progression of inflammatory diseases. MFG-E8 was shown to attenuate the progression of inflammation and to improve survival in septic rats. Accumulating evidence suggests an immun...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556065/ https://www.ncbi.nlm.nih.gov/pubmed/23324439 http://dx.doi.org/10.1186/1471-230X-13-14 |
_version_ | 1782257136096509952 |
---|---|
author | D’Haese, Jan G Demir, Ihsan Ekin Kehl, Timo Winckler, Jannik Giese, Nathalia A Bergmann, Frank Giese, Thomas Büchler, Markus W Friess, Helmut Hartel, Mark Ceyhan, Güralp O |
author_facet | D’Haese, Jan G Demir, Ihsan Ekin Kehl, Timo Winckler, Jannik Giese, Nathalia A Bergmann, Frank Giese, Thomas Büchler, Markus W Friess, Helmut Hartel, Mark Ceyhan, Güralp O |
author_sort | D’Haese, Jan G |
collection | PubMed |
description | BACKGROUND: The glycoprotein MFG-E8 mediates phagocytic clearance of apoptotic cells and influences the pathogenesis and progression of inflammatory diseases. MFG-E8 was shown to attenuate the progression of inflammation and to improve survival in septic rats. Accumulating evidence suggests an immunomodulatory link between MFG-E8 and the pro-inflammatory chemokine fractalkine, which may determine the severity of pain, fibrosis, and inflammation in chronic pancreatitis (CP). METHODS: The expression and localization of MFG-E8 was investigated in CP (n = 62), and normal pancreas (NP; n = 34) by QRT-PCR, Western-blot and immunohistochemistry analyses. Results were correlated with mRNA expression of fractalkine, CX3CR1, and with the presence and degree of pain and fibrosis. Human pancreatic stellate cells (hPSCs) were isolated from CP tissues and evaluated for MFG-E8 mRNA expression after fractalkine stimulation. RESULTS: MFG-E8-mRNA was significantly overexpressed in CP and isolated hPSCs when compared to NP. Western-blot and immunohistochemistry analysis confirmed accumulation of MFG-E8 in CP, with noticeably increased MFG-E8 immunoreactivity in tubular complexes. MFG-E8 expression correlated significantly with fractalkine expression, severe fibrosis, and the presence of pain in CP patients. Stimulation of hPSCs with fractalkine led to a significant increase in MFG-E8 expression. CONCLUSIONS: In the present study, we demonstrated for the first time that MFG-E8 is significantly up-regulated in CP patients and together with fractalkine correlated noticeably with severe fibrosis and the presence of pain. hPSCs overexpress MFG-E8 upon fractalkine stimulation in vitro, which underlines the suggested immunmodulatory link in CP and may be a key mechanism in CP fibrogenesis and pain generation. Taken together, these novel findings suggest that MFG-E8 blockade may be a promising tool for future immunotherapy in CP to attenuate both fibrosis and pain sensation. |
format | Online Article Text |
id | pubmed-3556065 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-35560652013-01-31 The impact of MFG-E8 in chronic pancreatitis: potential for future immunotherapy? D’Haese, Jan G Demir, Ihsan Ekin Kehl, Timo Winckler, Jannik Giese, Nathalia A Bergmann, Frank Giese, Thomas Büchler, Markus W Friess, Helmut Hartel, Mark Ceyhan, Güralp O BMC Gastroenterol Research Article BACKGROUND: The glycoprotein MFG-E8 mediates phagocytic clearance of apoptotic cells and influences the pathogenesis and progression of inflammatory diseases. MFG-E8 was shown to attenuate the progression of inflammation and to improve survival in septic rats. Accumulating evidence suggests an immunomodulatory link between MFG-E8 and the pro-inflammatory chemokine fractalkine, which may determine the severity of pain, fibrosis, and inflammation in chronic pancreatitis (CP). METHODS: The expression and localization of MFG-E8 was investigated in CP (n = 62), and normal pancreas (NP; n = 34) by QRT-PCR, Western-blot and immunohistochemistry analyses. Results were correlated with mRNA expression of fractalkine, CX3CR1, and with the presence and degree of pain and fibrosis. Human pancreatic stellate cells (hPSCs) were isolated from CP tissues and evaluated for MFG-E8 mRNA expression after fractalkine stimulation. RESULTS: MFG-E8-mRNA was significantly overexpressed in CP and isolated hPSCs when compared to NP. Western-blot and immunohistochemistry analysis confirmed accumulation of MFG-E8 in CP, with noticeably increased MFG-E8 immunoreactivity in tubular complexes. MFG-E8 expression correlated significantly with fractalkine expression, severe fibrosis, and the presence of pain in CP patients. Stimulation of hPSCs with fractalkine led to a significant increase in MFG-E8 expression. CONCLUSIONS: In the present study, we demonstrated for the first time that MFG-E8 is significantly up-regulated in CP patients and together with fractalkine correlated noticeably with severe fibrosis and the presence of pain. hPSCs overexpress MFG-E8 upon fractalkine stimulation in vitro, which underlines the suggested immunmodulatory link in CP and may be a key mechanism in CP fibrogenesis and pain generation. Taken together, these novel findings suggest that MFG-E8 blockade may be a promising tool for future immunotherapy in CP to attenuate both fibrosis and pain sensation. BioMed Central 2013-01-16 /pmc/articles/PMC3556065/ /pubmed/23324439 http://dx.doi.org/10.1186/1471-230X-13-14 Text en Copyright ©2013 D'Haese et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article D’Haese, Jan G Demir, Ihsan Ekin Kehl, Timo Winckler, Jannik Giese, Nathalia A Bergmann, Frank Giese, Thomas Büchler, Markus W Friess, Helmut Hartel, Mark Ceyhan, Güralp O The impact of MFG-E8 in chronic pancreatitis: potential for future immunotherapy? |
title | The impact of MFG-E8 in chronic pancreatitis: potential for future immunotherapy? |
title_full | The impact of MFG-E8 in chronic pancreatitis: potential for future immunotherapy? |
title_fullStr | The impact of MFG-E8 in chronic pancreatitis: potential for future immunotherapy? |
title_full_unstemmed | The impact of MFG-E8 in chronic pancreatitis: potential for future immunotherapy? |
title_short | The impact of MFG-E8 in chronic pancreatitis: potential for future immunotherapy? |
title_sort | impact of mfg-e8 in chronic pancreatitis: potential for future immunotherapy? |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556065/ https://www.ncbi.nlm.nih.gov/pubmed/23324439 http://dx.doi.org/10.1186/1471-230X-13-14 |
work_keys_str_mv | AT dhaesejang theimpactofmfge8inchronicpancreatitispotentialforfutureimmunotherapy AT demirihsanekin theimpactofmfge8inchronicpancreatitispotentialforfutureimmunotherapy AT kehltimo theimpactofmfge8inchronicpancreatitispotentialforfutureimmunotherapy AT wincklerjannik theimpactofmfge8inchronicpancreatitispotentialforfutureimmunotherapy AT giesenathaliaa theimpactofmfge8inchronicpancreatitispotentialforfutureimmunotherapy AT bergmannfrank theimpactofmfge8inchronicpancreatitispotentialforfutureimmunotherapy AT giesethomas theimpactofmfge8inchronicpancreatitispotentialforfutureimmunotherapy AT buchlermarkusw theimpactofmfge8inchronicpancreatitispotentialforfutureimmunotherapy AT friesshelmut theimpactofmfge8inchronicpancreatitispotentialforfutureimmunotherapy AT hartelmark theimpactofmfge8inchronicpancreatitispotentialforfutureimmunotherapy AT ceyhanguralpo theimpactofmfge8inchronicpancreatitispotentialforfutureimmunotherapy AT dhaesejang impactofmfge8inchronicpancreatitispotentialforfutureimmunotherapy AT demirihsanekin impactofmfge8inchronicpancreatitispotentialforfutureimmunotherapy AT kehltimo impactofmfge8inchronicpancreatitispotentialforfutureimmunotherapy AT wincklerjannik impactofmfge8inchronicpancreatitispotentialforfutureimmunotherapy AT giesenathaliaa impactofmfge8inchronicpancreatitispotentialforfutureimmunotherapy AT bergmannfrank impactofmfge8inchronicpancreatitispotentialforfutureimmunotherapy AT giesethomas impactofmfge8inchronicpancreatitispotentialforfutureimmunotherapy AT buchlermarkusw impactofmfge8inchronicpancreatitispotentialforfutureimmunotherapy AT friesshelmut impactofmfge8inchronicpancreatitispotentialforfutureimmunotherapy AT hartelmark impactofmfge8inchronicpancreatitispotentialforfutureimmunotherapy AT ceyhanguralpo impactofmfge8inchronicpancreatitispotentialforfutureimmunotherapy |